LFG
TLX

Larson Financial Group’s Telix Pharmaceuticals TLX Stock Holding History

Larson Financial Group’s Portfolio TLX Stock Details TLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.6K Buy
+899
New +$6.85K ﹤0.01% 2336
2025
Q4 		– Sell
-53
Closed -$507 – 3707
2025
Q3 		$507 Buy
+53
New +$649 ﹤0.01% 3100

Other funds holding TLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
PIC
Portland Investment Counsel Burlington, Ontario, Canada $312M AUM 53.32% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $12.5B AUM 18.49% 1-Year Est. Return
RBI
Raiffeisen Bank International Vienna, Austria $8.53B AUM 46.94% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

Larson Financial Group's TLX Position: Q1 2026 in Review

Larson Financial Group opened a new position in Telix Pharmaceuticals (TLX) in Q1 2026: 899 shares worth $8.6K. The stake represents ﹤0.01% of the portfolio and ranks #2336 among its holdings. This is a return to the name: Larson Financial Group previously reported a position in TLX as recently as Q3 2025.

Larson Financial Group first reported a position in TLX in Q3 2025 and has held it in 2 quarters since. 39 funds tracked by Wall St. Rank hold TLX as of Q1 2026.

  • Larson Financial Group held 899 shares of Telix Pharmaceuticals worth $8.6K as of Q1 2026.
  • Telix Pharmaceuticals was a new Larson Financial Group position in Q1 2026.
  • Telix Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #2336 holding.
  • Larson Financial Group first reported a position in Telix Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • 39 funds tracked by Wall St. Rank held Telix Pharmaceuticals as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.